期刊文献+

非小细胞肺癌组织中miR-449a/b/c的表达及临床意义 被引量:10

Analysis of miR-449a/b/c expressions and their clinical significance in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨非小细胞肺癌(NSCLC)组织中微小RNA(miRNA)-449a/b/c的表达水平、临床意义及与预后的关系。方法收集2013年1月至2015年12月收治的82例手术切除的NSCLC组织及69例癌旁组织标本,采用荧光实时定量PCR(QPCR)法检测以上组织中miR-449a/b/c的表达并比较3者在NSCLC组织及癌旁组织中的分布差异,Pearson相关分析NSCLC组织中miR-449a、miR-449b和miR-449c表达的相关性,分析NSCLC组织中miR-449a/b/c表达与临床病理特征(性别、年龄、肿瘤大小、TNM分期、组织学类型和淋巴结转移)的关系,同时根据随访数据比较不同miR-449a/b/c表达患者的预后情况。结果 QPCR结果显示,NSCLC组织中miR-449a、miR-449b和miR-449c的平均表达量依次为0.210±0.028、0.359±0.031和0.133±0.020,均低于癌旁组织,差异有统计学意义(P<0.05);NSCLC组织中miR-449a、miR-449b和miR-449c的表达均呈正相关,相关系数r_(miR-449a/b)、r_(miR-449a/c)和r_(miR-449b/c)分别为0.246、0.390和0.331(P<0.05);NSCLC组织中miR-449a/b/c表达均与TNM分期有关,miR-449a和miR-449c表达与肿瘤大小有关。全组中位总生存期(OS)为12.4个月,其中miR-449a低表达组和高表达组的中位OS分别为11.2个月和13.5个月(P>0.05),miR-449b低表达组和高表达组的中位OS分别为9.6个月和14.2个月(P<0.05),miR-449c低表达组和高表达组的中位OS分别为11.7个月和13.7个月(P>0.05)。结论miR-449a/b/c在NSCLC组织中表达降低,且均与TNM分期有关,miR-449b表达与预后有关,可能与NSCLC发生、发展有关,对NSCLC诊断及病情评估有一定价值。 Objective To investigate the expression and clinical significance of miR-449a/b/c in non-small cell lung cancer( NSCLC) as well as their expressions with prognosis. Methods We collected 82 cases of surgically resected NSCLC tissues and 69 cases of adjacent normal tissue( 〉 5 cm away from cancer tissue) from January 2013 to December 2015. The expressions of miR-449a/b/c of above tissues were detected by using real-time fluorescence quantitative PCR( QPCR). The differences of distribution of miR-449a/b/c expressions in NSCLC and adjacent normal tissues were compared. Pearson correlation analysis of miR-449 a,miR-449 b and miR-449 c in NSCLC tissues was undergone. The relationship of miR-449a/b/c expressions in NSCLC with clinical pathological parameters( gender,age,tumor size,TNM stage,histological type and lymph node metastasis) were analyzed. According to the followup data,the prognosis of different expressions of miR-449a/b/c was compared. Results QPCR results showed that in NSCLC tissues,the avarage expressions of miR-449 a,miR-449 b and miR-449 c were 0. 210 ± 0. 028,0. 359 ± 0. 031 and 0. 133 ± 0. 020,lower than those in adjacent normal tissues,and the differences were statistically significant( P 〈 0. 05). The expressions of miR-449 a,miR-449 b and miR-449 c were positively correlated in NSCLC and correlation coefficients for miR-449a/b,miR-449a/c and miR-449b/c were 0. 246,0. 390 and 0. 331( P 〈 0. 05). The miR-449a/b/c levels of NSCLC tissues were significantly associated with TNM stage,and miR-449 a and miR-449 c were related to tumor size. All patients were followed up,and the median overall survival( OS) was 12. 4months. The median OS for miR-449 a low expression group and high expression group were 11. 2 and 13. 5 months( P 〉 0. 05). The median OS for miR-449 b low expression group and high expression group were 9. 6 and 14. 2 months( P 〈 0. 05). The median OS for miR-449 c low expression group and high expression group were 11. 7 and 13. 7 months( P 〉 0. 05). Conclusion The expression of miR-449a/b/c in NSCLC tissues was decreased,and all of them were related to TNM stage. The expression of miR-449 b was related to prognosis,which may be related to the occurrence and development of NSCLC. It has some value in the diagnosis and evaluation of NSCLC.
出处 《临床肿瘤学杂志》 CAS 2017年第4期303-308,共6页 Chinese Clinical Oncology
关键词 非小细胞肺癌(NSCLC) 微小RNA-449a(miRNA-449a) 微小RNA-449b(miRNA-449b) 微小RNA-449c(miRNA-449c) Non-small cell lung cancer(NSCLC) MicroRNA-449a(miRNA-449a) MicroRNA-449b(miRNA-449b) MicroRNA-449c(miRNA-449c)
  • 相关文献

参考文献5

二级参考文献34

  • 1Ming Gao,Hao Yin,Zhe-Wei Fei.Clinical application of microRNA in gastric cancer in Eastern Asian area[J].World Journal of Gastroenterology,2013,19(13):2019-2027. 被引量:16
  • 2邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:151
  • 3Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection [J]. Proc Natl Acad Sci USA, 2008, 105 (30): 10513-10518.
  • 4Vora N, Reckamp KL. Non-small cell lung cancer: defining treatment options [ J ]. Semin Oncol, 2008, 35 (6) : 590-596.
  • 5Lam TK, Shao S, Zhao Y, et al. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues [J].Cancer Epidemiol Biomarkers Prey,2012, [ Epub ahead of print].
  • 6Kroh EM, Parkin RK, Mitchell PS,et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR ( qRT-PCR ) [J]. Methods, 2010,50(4) :298-301.
  • 7Faraoni I, Antonetti FR, Cardone J, et al. miR-155 gene: a typical multifunctional microRNA[ J ]. Biochim Biophys Acta, 2009,1792 ( 3 ) :497-505.
  • 8Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer [J]. Cancer Res, 2005, 65:7065-7070.
  • 9Kluiver J, Poppema S, de JD, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas [ J ]. J Pathol, 2005, 207 (2) : 243 -249.
  • 10Raponi M, Dossey L, Jatkoe T, et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer [ J ]. Cancer Res, 2009, 69(14) :5776-5783.

共引文献42

同被引文献45

引证文献10

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部